US FDA declines approval for Gilead’s rheumatoid arthritis drug, Filgotinib
The US drug regulator has issued a complete response letter requesting data from the MANTA and MANTA-RAy studies and expressing…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.